Literature DB >> 22661226

Phosphorylation puts the pRb tumor suppressor into shape.

Andreas M F Heilmann1, Nicholas J Dyson.   

Abstract

In this issue of Genes & Development, Burke and colleagues (pp. 1156-1166) describe how the structure of retinoblastoma protein (pRb) is altered by phosphorylation at T373 or S608. These modifications cause specific conformational changes and alter pRb's interaction with E2F via two distinct mechanisms. The structures suggest that the panel of phosphorylation sites represents a versatile set of tools that are used to sculpt pRb in precise, but very different, ways.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22661226      PMCID: PMC3371403          DOI: 10.1101/gad.195552.112

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  22 in total

1.  Cumulative effect of phosphorylation of pRB on regulation of E2F activity.

Authors:  V D Brown; R A Phillips; B L Gallie
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

2.  Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases.

Authors:  T Zarkowska; S Mittnacht
Journal:  J Biol Chem       Date:  1997-05-09       Impact factor: 5.157

3.  Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for phosphorylation-induced E2F release.

Authors:  Seth M Rubin; Anne-Laure Gall; Ning Zheng; Nikola P Pavletich
Journal:  Cell       Date:  2005-12-16       Impact factor: 41.582

4.  Dual mechanisms for the inhibition of E2F binding to RB by cyclin-dependent kinase-mediated RB phosphorylation.

Authors:  E S Knudsen; J Y Wang
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

5.  Reverse mutational analysis reveals threonine-373 as a potentially sufficient phosphorylation site for inactivation of the retinoblastoma tumor suppressor protein (pRB).

Authors:  Nathan H Lents; Laura L Gorges; Joseph J Baldassare
Journal:  Cell Cycle       Date:  2006-08-01       Impact factor: 4.534

Review 6.  The retinoblastoma protein and cell cycle control.

Authors:  R A Weinberg
Journal:  Cell       Date:  1995-05-05       Impact factor: 41.582

7.  Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation.

Authors:  P L Chen; P Scully; J Y Shew; J Y Wang; W H Lee
Journal:  Cell       Date:  1989-09-22       Impact factor: 41.582

8.  Crystal structure of the retinoblastoma protein N domain provides insight into tumor suppression, ligand interaction, and holoprotein architecture.

Authors:  Markus Hassler; Shradha Singh; Wyatt W Yue; Maciej Luczynski; Rachid Lakbir; Francisco Sanchez-Sanchez; Thomas Bader; Laurence H Pearl; Sibylle Mittnacht
Journal:  Mol Cell       Date:  2007-11-09       Impact factor: 17.970

9.  A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma.

Authors:  S H Friend; R Bernards; S Rogelj; R A Weinberg; J M Rapaport; D M Albert; T P Dryja
Journal:  Nature       Date:  1986 Oct 16-22       Impact factor: 49.962

10.  Structural basis for the recognition of the E2F transactivation domain by the retinoblastoma tumor suppressor.

Authors:  Changwook Lee; Jeong Ho Chang; Hyun Sook Lee; Yunje Cho
Journal:  Genes Dev       Date:  2002-12-15       Impact factor: 11.361

View more
  6 in total

1.  Molecular Determinants for the Inactivation of the Retinoblastoma Tumor Suppressor by the Viral Cyclin-dependent Kinase UL97.

Authors:  Satoko Iwahori; Morgan Hakki; Sunwen Chou; Robert F Kalejta
Journal:  J Biol Chem       Date:  2015-06-21       Impact factor: 5.157

2.  A comparative study of Whi5 and retinoblastoma proteins: from sequence and structure analysis to intracellular networks.

Authors:  Md Mehedi Hasan; Stefania Brocca; Elena Sacco; Michela Spinelli; Elena Papaleo; Matteo Lambrughi; Lilia Alberghina; Marco Vanoni
Journal:  Front Physiol       Date:  2014-01-21       Impact factor: 4.566

Review 3.  The Retinoblastoma (RB) Tumor Suppressor: Pushing Back against Genome Instability on Multiple Fronts.

Authors:  Renier Vélez-Cruz; David G Johnson
Journal:  Int J Mol Sci       Date:  2017-08-16       Impact factor: 5.923

4.  Phosphorylation of pRb: mechanism for RB pathway inactivation in MYCN-amplified retinoblastoma.

Authors:  Kathryn G Ewens; Tricia R Bhatti; Kimberly A Moran; Jennifer Richards-Yutz; Carol L Shields; Ralph C Eagle; Arupa Ganguly
Journal:  Cancer Med       Date:  2017-02-17       Impact factor: 4.452

5.  RNA-binding protein MEX3A controls G1/S transition via regulating the RB/E2F pathway in clear cell renal cell carcinoma.

Authors:  Yuntan Qiu; Meng Meng; Chuanzhen Cao; Jingyuan Zhang; Xu Cheng; Yongxin Huang; Haotian Cao; Yun Li; Duanqing Tian; Yongsheng Huang; Li Peng; Kaishun Hu; Yin Zhang; Jianyou Liao; Jiehua He; Xiaochun Wang; Daning Lu; Lehang Lin; Xingang Bi; Dong Yin
Journal:  Mol Ther Nucleic Acids       Date:  2021-12-02       Impact factor: 8.886

6.  Mitochondrial ferritin, a new target for inhibiting neuronal tumor cell proliferation.

Authors:  Zhen-Hua Shi; Fang-Fang Shi; Yue-Qi Wang; Alex D Sheftel; Guangjun Nie; Ya-Shuo Zhao; Lin-Hao You; Yu-Jing Gou; Xiang-Lin Duan; Bao-Lu Zhao; Hong-Meng Xu; Chun-Yan Li; Yan-Zhong Chang
Journal:  Cell Mol Life Sci       Date:  2014-09-12       Impact factor: 9.261

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.